At busy Visp site, Lon­za will up mi­cro­bial ser­vices by 50%

In an ef­fort to up its de­vel­op­ment of mi­cro­bial-de­rived pro­teins, Swiss CD­MO Lon­za will in­vest in its man­u­fac­tur­ing ca­pac­i­ties in its home coun­try.

The ex­ten­sion will be good to go by the end of this year, the com­pa­ny said. The ex­pand­ed de­vel­op­ment will strength­en the up­stream, down­stream and process an­a­lyt­ics sup­port for new projects. The mi­cro­bial foot­print at its Visp site will be con­sol­i­dat­ed, and new high-through­put equip­ment and au­toma­tion process­es will be added to in­crease ef­fi­cien­cy and project de­liv­ery. That will in­clude three liq­uid han­dling work­sta­tions, and the up­grades will help im­prove da­ta gen­er­a­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER